Akorn Inc (AKRX.O)
FRANKFURT, May 12 The head of German healthcare group Fresenius SE said he would abstain from the takeover market for now, after striking three deals worth billions of euros in total since taking over less than a year ago.
FRANKFURT German healthcare group Fresenius on Wednesday toned up its earnings guidance for the year as demand for recently launched generic infusion drugs continued to grow at higher-than-expected rates.
FRANKFURT, May 3 German healthcare group Fresenius SE & Co KGaA on Wednesday lifted its guidance on strong demand in the United States for its generic infusion drugs.
April 25 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Tuesday:
FRANKFURT German healthcare group Fresenius SE & Co KGaA has stepped up its dealmaking, agreeing to buy U.S. generic drugmaker Akorn Inc for $4.75 billion (4.37 billion euros) and the biosimilars arm of Germany's Merck KGaA.
* Fresenius shares up almost 1 percent (Adds advisers, shares, background, CEO, analyst comments)
FRANKFURT, April 25 The DAX top-30 index looked set to open 0.3 percent higher on Tuesday, according to premarket data from brokerage Lang & Schwarz at 0625 GMT.
* Akorn - deal with Fresenius Kabi provides under specified circumstances, co to be required to pay Fresenius Kabi AG termination fee of $129 million Source text: (http://bit.ly/2oEMWQV) Further company coverage:
FRANKFURT, April 24 Acquisitive German healthcare conglomerate Fresenius SE & Co KGaA revved up its deals pace by acquiring U.S. generic drugmaker Akorn Inc for $4.75 billion (4.37 billion euros), and in a separate deal, the biosimilars unit of German peer Merck KGaA .
German healthcare conglomerate Fresenius SE & Co KGaA is close to acquiring generic drugmaker Akorn Inc in an all-cash deal valuing the company at more than $4 billion, people familiar with the matter said on Monday.
|Novartis AG (NOVN.S)||CHF79.10||+0.05|
|Pfizer Limited (PFIZ.NS)||Rs1,678.35||-13.35|
|Hikma Pharmaceuticals Plc (HIK.L)||1,665.00||-6.00|
|Fresenius Kabi Oncology Ltd (FRES.M3)||--||--|
|Mylan NV (MYL.OQ)||$39.51||+0.34|
|Taro Pharmaceutical Industries Ltd. (TARO.N)||$105.63||+1.22|
|Valeant Pharmaceuticals Intl Inc (VRX.TO)||$17.28||-0.08|
|Johnson & Johnson (JNJ.N)||$126.96||-0.55|